JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 31 No. 1 23-31
© 1990 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kairemo, K. J.A.
Right arrow Articles by Blomqvist, C. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kairemo, K. J.A.
Right arrow Articles by Blomqvist, C. P.

Imaging of Soft-Tissue Sarcomas with Indium-111-Labeled Monoclonal Antimyosin Fab Fragments

Kalevi J.A. Kairemo, Tom A. Wiklund, Kristian Liewendahl, Markku Miettinen, Jorma J. Heikkonen, Pekka J. Virkkunen, Hannu J. Aronen and Carl P. Blomqvist

Department ofClinical Chemistry, Division of Nuclear Medicine, Department of Radiotherapy and Oncology, and Department of Pathology, Helsinki University Central Hospital, Helsinki, Finland

Correspondence: For reprints contact: Kalevi J.A. Kairemo, MD, MSc(Eng), Div. of Nuclear Medicine, Helsinki University Central Hospital, Haartmaninkatu 4, SF-00290 Helsinki, Finland.

ABSTRACT

Some soft-tissue sarcomas contain intracellular myosin. We therefore studied the possibility of localizing various soft-tissue sarcomas with 111In-labeled monoclonal antibody Fab fragments binding specifically to myosin, assuming that damage to the cell membrane could expose intracellular myosin. Nineteen patients with different types of soft-tissue sarcomas were studied. Eighteen patients were found to have abnormal antibody uptakes. Antibody uptake was not observed in an additional patient operated for a benign tumor (gastric leiomyoma). The immunoscintigraphy results were generally in good agreement with those of other radiologic findings (computed tomography, ultrasound, magnetic resonance imaging). Surprisingly, the immunohistochemistry results showed that tumors not stainable for myosin can also be imaged with antimyosin. Thus, the mechanism of antibody uptake does not seem to be related entirely to specific antigen recognition. Irrespective of the exact mechanism for the uptake of labeled antibody this method appears to be useful for localizing soft-tissue sarcomas.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
F. Al-Ejeh, J. M. Darby, K. Pensa, K. R. Diener, J. D. Hayball, and M. P. Brown
In vivo Targeting of Dead Tumor Cells in a Murine Tumor Model Using a Monoclonal Antibody Specific for the La Autoantigen
Clin. Cancer Res., September 15, 2007; 13(18): 5519s - 5527s.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
M. Lofberg, K. Liewendahl, A. Lamminen, O. Korhola, and H. Somer
Antimyosin Scintigraphy Compared With Magnetic Resonance Imaging in Inflammatory Myopathies
Arch Neurol, July 1, 1998; 55(7): 987 - 993.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
K. J.A. Kairemo, C. P. Blomqvist, M. Miettinen, R. Stern, K. Reynen, and W. G. Daniel
Cardiac Myxomas
N. Engl. J. Med., May 23, 1996; 334(21): 1407 - 1409.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1990 by the Society of Nuclear Medicine.